Octreotide Market to Represent Healthy Growth by 2026

Anjali Pawar13 Dec, 2021Business

The surge in the number of patients who go undiagnosed with cancer has fueled demand for octreotide. In 2012, it was estimated that 14.1 million people were diagnosed with cancer. The number of people diagnosed with cancer is expected to reach over 24 million by 2035. As a result, the demand for pharmaceuticals like octreotide for therapy is expected to rise, according to the forecast. According to available data, severe diarrhoea kills 2200 children per year, more than measles, malaria, and AIDS combined, according to the World Health Organization.